Stmt re: Suspension

RNS Number:4568J
Lombard Medical PLC
01 April 2003

1 April 2003
Embargoed until 7.05 a.m.

                              Lombard Medical plc

                            Statement re suspension


The shares of Lombard Medical plc were suspended from AIM with effect from 7am
this morning, 1 April 2003, following the failure of the company to publish its
accounts for its financial year ended 30 September 2002 within the 6 month
period laid down by the AIM Rules. The purpose of this announcement is to update
shareholders on those matters set out in the Company's announcement released on
18 March 2003 which related, principally, to the funding position of the
Company, the talks that may or may not lead to an offer being made for the
entire share capital of the Company and the likely timing of the posting to
shareholders of the annual report and accounts.

The Independent Board remains in advanced talks that may or may not result in an
offer being made for the entire issued share capital of the Company.  No formal
offer for the Company has been made or received at this time but the Board is
hopeful that a formal offer will be forthcoming in the near future.  The
Independent Board believes that if an offer is forthcoming, it is likely to be
in the form of a share for share offer with no cash alternative.

The Directors have been giving urgent consideration to the financial position of
Lombard Medical and the Company's bankers continue to indicate that they would
not expect to call for repayment of the current bank facility whilst these
talks, regarding an offer for the Company, are ongoing.  If no offer is
forthcoming, the Board believes that the Company's bankers would not be prepared
to increase or extend the Company's current banking facilities, which remain
repayable on demand.

The Board believes that the making of a formal offer pursuant to these talks
should allow the Company to post its report and accounts for the year ended 30
September 2002 to shareholders.  Due to the likely conditions attached to the
offer, the accounts may be on a qualified basis.  Following the posting of the
report and accounts to shareholders, the Company's shares will be restored to
trading on AIM.

Shareholders will be kept informed of all relevant developments.

Terms used in this announcement have the same meaning as those defined in the
Company's announcement dated 18 March 2003.


Enquiries:


Christopher Stainforth                    020 7459 3600
Chairman of the Independent Board
Lombard Medical plc


Simon Hirst/Richard Swindells             020 7459 3600
Durlacher Limited
Nominated Adviser to Lombard Medical


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

SRSWUUQGWUPWGRG